AORT vs ARAY Valuation Comparison 2026 — Intrinsic Value Analysis

Quick Summary — AORT scores higher on quality with 8.2/10 vs ARAY's 4.3/10. AORT trades at $21.04 while ARAY trades at $0.39. Both analyzed daily using SEC EDGAR data across 13 institutional models.

AORT

Medical Devices

Artivion, Inc.

Quality

8.2

out of 10

Value Trap

29

LOW

Price

$21.04

Last close

Models

10/13

Active

VS

ARAY

Medical Devices

Accuray Incorporated

Quality

4.3

out of 10

Value Trap

12

SAFE

Price

$0.39

Last close

Models

5/13

Active

AORT

Quality Score 8.2/10 — top tier

Limited to 2/13 visible models

ARAY

Earnings Power Value sees +41.4% upside

Quality 4.3/10 — below average

AORT vs ARAY — Fair Value Comparison

AORT

ARAY

Market Price Model 1 Model 2

Model-by-Model Comparison

Model	Type	AORT Fair Value	AORT Upside	ARAY Fair Value	ARAY Upside
Bayesian DCF	Intrinsic	$3.41	-84.8%	—	—
Earnings Power Value	Intrinsic	$0.37	-98.2%	$0.66	+41.4%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$5.67	-73.0%	$0.03	-93.5%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

AORT vs ARAY — Which Stock Is More Undervalued in 2026?

AORT scores higher with a 8.2/10 quality rating vs ARAY's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do AORT and ARAY Valuations Compare?

AORT currently trades at $21.04 while ARAY trades at $0.39. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily for both companies.

Quality of Company: AORT vs ARAY

AORT earns a Quality of Company score of 8.2/10 compared to ARAY's 4.3/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: AORT vs ARAY

AORT carries a LOW value trap risk (29/100) while ARAY shows SAFE risk (12/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.

Both in Medical Devices

Both AORT and ARAY operate in Medical Devices, which has 10 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare AORT vs ARAY differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

AORT

View Full Artivion, Inc. Analysis →

ARAY

View Full Accuray Incorporated Analysis →